For routine chemistry testing, the instrumentation is changing from the Roche Cobas c701 to the Roche Cobas c503 instrument. For routine immunoassay testing, the instrumentation is changing from the Siemens Centaur chemiluminescence immunoassay to the Roche Cobas e801 electrochemiluminescence immunoassay technology. In addition to these changes, Dynacare will also be bringing Insulin, Sex Hormone Binding Globulin (SHBG) and Bioavailable Testosterone testing in-house on these instruments.
Read More: Change to Routine Chemistry and Immunoassay Testing Platform - (BC Only)